Novelix Pharmaceuticals Limited (NOVELIX) Share Price
BSE · Healthcare · Medical Distribution · ISIN INE314I01036
₹81.90+1.40 (+1.74%)
Key metrics
- Market Cap
- ₹222 Cr
- P/E Ratio
- 48.45
- EPS
- 1.61
- Book Value
- 22.05
- P/B Ratio
- 3.71
- ROE
- 5.5%
- ROCE
- 6.64%
- Debt / Equity
- 0.09
- Net Margin
- 1.93%
- Revenue Growth
- 330.71%
- Profit Growth
- 2,925.56%
- Dividend Yield
- —
- 52W High
- ₹92.00
- 52W Low
- ₹38.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Novelix Pharmaceuticals Limited
Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 75.05%
The full Novelix Pharmaceuticals Limited analysis
Create a free account to open the complete NOVELIX deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.